Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Big Pharma Defuses Drug Pricing Landmines On Capitol Hill

Feb 26 2019

• By Jessica Merrill

Pharma CEOs testify at Senate Finance Committee hearing 2-26-19 — • Source: Win McNamee/Getty Images (Win McNamee/Getty Images)

Related Content

Medicare IPI Model Could Import Benefit Of Biosimilar Competition, Azar Suggests

Jan 16 2019

Senate Drug Pricing Hearing Looms As Unparalleled Event For Pharma

Feb 22 2019

Senate Drug Pricing Hearing Looms As Unparalleled Event For Pharma

Feb 22 2019

Related Companies

Pfizer Inc.

AstraZeneca PLC

Sanofi

Johnson & Johnson

Bristol Myers Squibb Company

Merck & Co., Inc.

AbbVie Inc.

Horizon Therapeutics plc

Additional Topics

United States Pricing Debate Legislation Leadership Government Payers Policy BioPharmaceutical

More from Drug Pricing

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.